Form 8-K - Current report:
SEC Accession No. 0001628280-21-002232
Filing Date
2021-02-16
Accepted
2021-02-16 13:43:30
Documents
4
Period of Report
2021-02-16
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crdf8-k021621.htm 8-K 28576
2 EX-99.1 a991excrdf021621.htm EX-99.1 11269
3 cardiff_logoxrgbxtm1a.jpg GRAPHIC 176318
4 image_01.jpg GRAPHIC 50931
  Complete submission text file 0001628280-21-002232.txt   339525
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Filer) CIK: 0001213037 (see all company filings)

EIN.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35558 | Film No.: 21635777
SIC: 2836 Biological Products, (No Diagnostic Substances)